JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.45 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $258,000 | +239.5% | 29,536 | +29.0% | 0.22% | +278.9% |
| Q3 2019 | $76,000 | -59.8% | 22,904 | -40.1% | 0.06% | -51.3% |
| Q2 2019 | $189,000 | -39.8% | 38,222 | -24.5% | 0.12% | -9.3% |
| Q1 2019 | $314,000 | +15.4% | 50,622 | -37.3% | 0.13% | +13.2% |
| Q4 2018 | $272,000 | +30.1% | 80,710 | +151.5% | 0.11% | -30.9% |
| Q3 2018 | $209,000 | -74.8% | 32,086 | -70.4% | 0.16% | -27.6% |
| Q2 2018 | $831,000 | – | 108,517 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 9,200,349 | $64,402,000 | 44.86% |
| TRV GP III, LLC | 3,048,780 | $21,342,000 | 1.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 406,665 | $2,847,000 | 1.65% |
| Sofinnova Investments, Inc. | 925,280 | $6,477,000 | 0.39% |
| Omega Fund Management, LLC | 334,965 | $2,345,000 | 0.35% |
| Yorktown Management & Research Co Inc | 49,200 | $344,000 | 0.31% |
| Woodline Partners LP | 940,902 | $6,586,000 | 0.18% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 51,000 | $357,000 | 0.09% |
| HORIZON FINANCIAL SERVICES, LLC | 12,005 | $84,000 | 0.08% |
| Gyon Technologies Capital Management, LP | 26,893 | $188,000 | 0.06% |